AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

Each Tablet Contains: Vildagliptin 50,0 Mg, Metformin Hydrochloride 850,0 Mg

11 registrations across 1 African market— 11 active

Markets with Each Tablet Contains: Vildagliptin 50,0 Mg, Metformin Hydrochloride 850,0 Mg

🇿🇦South Africa
11 registrations
11 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
AVILMET 50 mg/850 mg🇿🇦South AfricaAccord Healthcare (Pty) LtdactiveFeb 2031
DIAMVIL 50 mg/850 mg🇿🇦South AfricaAccord Healthcare (Pty) LtdactiveFeb 2031
VIDIABMET 50/850🇿🇦South AfricaPharma-Q (Pty) LtdactiveFeb 2031
GALVUS MET 50 mg/850 mg🇿🇦South AfricaNovartis South Africa (Pty) LtdactiveNov 2030
VILCOMET 50/850🇿🇦South AfricaTrinity Pharma (Pty) LtdactiveAug 2030
ZOMVIL CO 50/850🇿🇦South AfricaTrinity Pharma (Pty) LtdactiveAug 2030
XYVILIN CO 50/850🇿🇦South AfricaTrinity Pharma (Pty) LtdactiveAug 2030
VIGLYMAK PLUS 50/850🇿🇦South AfricaMacleods Pharmaceuticals SA (Pty) LtdactiveJun 2030
VILDAGLYMIN 50/850🇿🇦South AfricaMacleods Pharmaceuticals SA (Pty) LtdactiveJun 2030
VIDAMACE PLUS🇿🇦South AfricaPharma Dynamics (Pty) LtdactiveMay 2030
JALRAMET 50/850 mg🇿🇦South AfricaNovartis South Africa (Pty) LtdactiveMay 2024

Each Tablet Contains: Vildagliptin 50,0 Mg, Metformin Hydrochloride 850,0 Mg in Africa — Regulatory Overview

Each Tablet Contains: Vildagliptin 50,0 Mg, Metformin Hydrochloride 850,0 Mg is registered across 1 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 11 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.